| Stephany Amanda Cochran, ASCP(CM) | |
|
930 Maple St, North Liberty, IA 52317-9085 | |
| (319) 899-9239 | |
| Not Available |
| Full Name | Stephany Amanda Cochran |
|---|---|
| Gender | Female |
| Speciality | Pathology - Clinical Pathology/laboratory Medicine |
| Location | 930 Maple St, North Liberty, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538795240 | NPI | - | NPPES |
| 2541948 | Other | IA | ASCP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0105X | Pathology - Clinical Pathology/laboratory Medicine | 2541948 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephany Amanda Cochran, ASCP(CM) 930 Maple St, North Liberty, IA 52317-9085 Ph: (319) 899-9239 | Stephany Amanda Cochran, ASCP(CM) 930 Maple St, North Liberty, IA 52317-9085 Ph: (319) 899-9239 |
News Archive
Experts from 11 countries will gather this week in Rome to discuss innovative strategies for studying and treating Inflammatory Bowel Diseases.
The Heilbrunn Department of Population and Family Health at the Columbia University Mailman School of Public Health announced today the creation of the Jennifer Schlecht Memorial Scholarship for Sexual and Reproductive Health Justice in Fragile Settings which will be awarded annually as part of the Jennifer Schlecht Memorial Fund, hosted by Family Planning 2030 (FP2030) at the United Nations Foundation.
SNM's Molecular Imaging Center of Excellence wrapped up its Molecular Neuroimaging Symposium today in Bethesda, Md., at the Natcher Auditorium of the National Institutes of Health (NIH).
OSI Pharmaceuticals, Inc. announced today its financial results for the first quarter ended March 31, 2010. The Company reported total revenues from continuing operations of $107 million for the first quarter of 2010, a 14% increase over revenues of $94 million for the first quarter of 2009.
› Verified 2 days ago